Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • State News

    State News - Page 5

    Lupin gets USFDA nod for generic equivalent of Depakote ER Tablets to treat epilepsy in US

    Lupin gets USFDA nod for generic equivalent of Depakote ER Tablets to treat epilepsy in US

    Medical Dialogues Bureau23 Oct 2019 11:38 AM IST
    "The United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Depakote Extended-Release Tablets, 250 mg and 500 mg, of...
    Hyderabad Pharma City Project: KTR seeks Rs 1318 crore assistance from Centre

    Hyderabad Pharma City Project: KTR seeks Rs 1318 crore assistance from Centre

    Medical Dialogues Bureau22 Oct 2019 9:45 AM IST
    The minister contended that Hyderabad Pharma City is the "world's largest integrated pharma park" to promote domestic manufacturing of pharmaceuticals...
    Parliamentary panel to now examine regulation, control of medical devices

    Parliamentary panel to now examine regulation, control of medical devices

    Medical Dialogues Bureau21 Oct 2019 2:20 PM IST
    New Delhi: A parliamentary panel has decided to examine regulation and control of medical devices in the country to ensure that they meet certain...
    Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in India

    Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in India

    Medical Dialogues Bureau18 Oct 2019 1:50 PM IST
    Mumbai: Cipla Limited announces the acquisition of a novel and patented anti-infective product, Elores, from Venus Remedies Limited ("VRL") for the...
    Glenmark Receives USFDA ANDA Approval for Abiraterone Acetate Tablets USP, 250 mg

    Glenmark Receives USFDA ANDA Approval for Abiraterone Acetate Tablets USP, 250 mg

    Medical Dialogues Bureau18 Oct 2019 1:40 PM IST
    MUMBAI -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA)...
    USFDA red flag to Torrent Pharmas Indrad facility

    USFDA red flag to Torrent Pharma's Indrad facility

    Medical Dialogues Bureau18 Oct 2019 1:15 PM IST
    New Delhi: The US health regulator has red-flagged Torrent Pharmaceuticals for significant violations of current good manufacturing practice (CGMP)...
    USFDA red flags Glenmark over batch failure investigations at Baddi facility

    USFDA red flags Glenmark over batch failure investigations at Baddi facility

    Medical Dialogues Bureau17 Oct 2019 1:28 PM IST
    New Delhi: The US health regulator has red flagged Glenmark Pharmaceuticals for failing to thoroughly investigate violation of manufacturing norms and...
    Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficulties

    Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficulties

    Medical Dialogues Bureau17 Oct 2019 1:14 PM IST
    New Delhi: Sun Pharmaceutical Industries recently announced that one of its wholly-owned subsidiaries has launched Drizalma Sprinkle™ (duloxetine...
    Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

    Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration

    Medical Dialogues Bureau17 Oct 2019 12:19 PM IST
    "This is the first time in India when such large number of pharmacists have been penalised. We have also issued warnings to around 3,000 pharmacists...
    Punjab: Chemist shot for denying habit-forming drug to patient

    Punjab: Chemist shot for denying habit-forming drug to patient

    Farhat Nasim12 Oct 2019 3:36 PM IST
    The chemist tried to explain to him the restrictions imposed on providing habit-forming drugs sans prescription. However, the miscreants fired at him...
    Accused of Swindling lakhs of rupees, Pharma sales representative hangs self

    Accused of Swindling lakhs of rupees, Pharma sales representative hangs self

    Farhat Nasim11 Oct 2019 3:05 PM IST
    The incident triggered everyone and the deceased's kin filed a complaint with the Byatarayanapura police alleging that the pharma firm's manager...
    Chennai-based Shield Healthcare acquires Brio Bliss Life Science, Nutri Synapzz

    Chennai-based Shield Healthcare acquires Brio Bliss Life Science, Nutri Synapzz

    Medical Dialogues Bureau4 Oct 2019 9:15 AM IST
    Shield Healthcare said pharmaceuticals and healthcare-focused private equity firm, Fulcrum Venture would also hold significant stake post the...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    KKRs Envision Healthcare hires bank to explore debt restructuring: Report

    KKR's Envision Healthcare hires bank to explore debt restructuring: Report

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Jubilant Life Sciences Karnataka plant shut on coronavirus scare

    Jubilant Life Sciences Karnataka plant shut on coronavirus scare

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok